COVID-19 and the cardiovascular system

Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China

Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30183-5 · Cited by 48,884

A pneumonia outbreak associated with a new coronavirus of probable bat origin

Zhou, P., Yang, X.-L., Wang, X.-G., Hu, B., Zhang, L., Zhang, W., Si, H.-R., Zhu, Y., Li, B., Huang, C.-L., et al. (2020) · Nature · doi:10.1038/s41586-020-2012-7 · Cited by 21,969

Clinical characteristics of 138 hospitalized patients with 2019 Novel Coronavirus-Infected pneumonia in Wuhan, China

Wang, D., Hu, B., Hu, C., Zhu, F., Liu, X., Zhang, J., Wang, B., Xiang, H., Cheng, Z., Xiong, Y., et al. (2020) · JAMA · doi:10.1001/jama.2020.1585 · Cited by 20,148

La certeza de lo impredecible: Cultura Educación y Sociedad en tiempos de COVID19

Martínez González, M. (2020) · DSPACE System - Metalibrary (University of the Coast) · Cited by 18,463

A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster

Chan, J., Yuan, S.-F., Kok, K.-H., To, K., Chu, H., Yang, J., Xing, F., Liu, J.-L., Yip, C., Poon, R., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30154-9 · Cited by 8,450

Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome

Wong, C. K., LAM, C. W. K., Wu, A. K. L., Ip, W., Lee, N. L. S., Chan, I., Lit, L. C. W., Hui, D. S. C., Chan, M. H. M., CHUNG, S. S. C., et al. (2004) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2004.02415.x · Cited by 1,270

Prevalence of comorbidities in the Middle East respiratory syndrome coronavirus (MERS-CoV): a systematic review and meta-analysis

Badawi, A. F., & Ryoo, S. G. (2016) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2016.06.015 · Cited by 703

ACE2: from vasopeptidase to SARS virus receptor

Turner, A. J., Hiscox, J. A., & Hooper, N. M. (2004) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2004.04.001 · Cited by 517

Altered Lipid Metabolism in Recovered SARS Patients Twelve Years after Infection

Wu, Q., Zhou, L., Sun, X., Yan, Z., Hu, C., Wu, J., Xu, L., Li, X., Liu, H., Yin, P., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-09536-z · Cited by 439

Acute myocarditis associated with novel Middle East respiratory syndrome coronavirus

Alhogbani, T. (2016) · Annals of Saudi Medicine · doi:10.5144/0256-4947.2016.78 · Cited by 353

Long COVID Definition, Symptoms, Risk Factors, Epidemiology and Autoimmunity: A Narrative Review

Kozłowski, P., Leszczyńska, A., & Ciepiela, O. (2024) · American Journal of Medicine Open · doi:10.1016/j.ajmo.2024.100068 · Cited by 27

Navigating the Diagnostics of COVID-19

Sanyaolu, A. O., Okorie, C., Marinkovic, A., Ayodele, O., Abbasi, A. F., Prakash, S., Ahmed, M., Kayode, D., Jaferi, U., & Haider, N. (2020) · SN Comprehensive Clinical Medicine · doi:10.1007/s42399-020-00408-8 · Cited by 25

Histopathological findings in the advanced natural evolution of the SARS-CoV-2 infection

Cîrstea, A. E., Buzulică, R., Pirici, D. N., Ceaușu, M. C., Iman, R. V., Gheorghe, O.-M., Neamțu, S. D., Stanca, L., Ene, R., Kumar‐Singh, S., et al. (2020) · Romanian Journal of Morphology and Embryology · doi:10.47162/rjme.61.1.23 · Cited by 25

Prevalence of cardiovascular symptoms in post-acute COVID-19 syndrome: a meta-analysis

Huang, L., Li, H., He, B., Wang, X.-B., Zhang, Q., & Wen-xing, P. (2025) · BMC Medicine · doi:10.1186/s12916-025-03908-3 · Cited by 26

Oncocardiology: new challenges, new opportunities

Michel, L., Schadendorf, D., & Rassaf, T. (2020) · Herz · doi:10.1007/s00059-020-04951-x · Cited by 25

Acetylated K676 TGFBIp as a severity diagnostic blood biomarker for SARS-CoV-2 pneumonia

Park, H. H., Kim, H. N., Kim, H., Yoo, Y., Shin, H., Choi, E. Y., Bae, J., & Lee, W. (2020) · Science Advances · doi:10.1126/sciadv.abc1564 · Cited by 25

The Prognostic Factors Affecting the Survival of Kurdistan Province COVID-19 Patients: A Cross-sectional Study From February to May 2020

Zandkarimi, E., Moradi, G., & Mohsenpour, B. (2020) · International Journal of Health Policy and Management · doi:10.34172/ijhpm.2020.155 · Cited by 25

Mortality and morbidity in patients with congenital heart disease hospitalised for viral pneumonia

Diller, G., Enders, D., Lammers, A. E., Orwat, S., Schmidt, R., Radke, R., Gerß, J., Alba, F. D. T., Kaleschke, G., Bauer, U. M. M., et al. (2020) · Heart · doi:10.1136/heartjnl-2020-317706 · Cited by 26

The Impact of Diabetes Mellitus in COVID-19: A Mechanistic Review of Molecular Interactions

Yaribeygi, H., Sathyapalan, T., Jamialahmadi, T., & Sahebkar, A. (2020) · Journal of Diabetes Research · doi:10.1155/2020/5436832 · Cited by 29

Comparison of patients hospitalized with COVID-19, H7N9 and H1N1

Deng, L., Yuan, J., Ding, L., Chen, Y., Zhao, C.-H., Chen, G., Li, X., Li, X., Luo, W.-T., Lan, J., et al. (2020) · Infectious Diseases of Poverty · doi:10.1186/s40249-020-00781-5 · Cited by 25

Is Spironolactone the Preferred Renin–Angiotensin–Aldosterone Inhibitor for Protection Against COVID-19?

Wilcox, C. S., & Pitt, B. (2020) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000000960 · Cited by 25

Complement activation and coagulopathy - an ominous duo in COVID19

Tomo, S., Kumar, K. P., Roy, D., Sankanagoudar, S., Purohit, P., Yadav, D., Banerjee, M., Sharma, P., & Misra, S. (2021) · Expert Review of Hematology · doi:10.1080/17474086.2021.1875813 · Cited by 27

Understanding Viral Infection Mechanisms and Patient Symptoms for the Development of COVID-19 Therapeutics

Choi, H. M., Moon, S. Y., Yang, H.-I., & Kim, K. S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22041737 · Cited by 28

How Do Inflammatory Mediators, Immune Response and Air Pollution Contribute to COVID-19 Disease Severity? A Lesson to Learn

Signorini, C., Pignatti, P., & Coccini, T. (2021) · Life · doi:10.3390/life11030182 · Cited by 25

Severe Acute Respiratory Syndrome–Associated Coronavirus 2 Infection and Organ Dysfunction in the ICU: Opportunities for Translational Research

Verhoef, P. A., Kannan, S., Sturgill, J., Tucker, E. W., Morris, P. E., Miller, A. C., Sexton, T. R., Koyner, J. L., Hejal, R. B., Brakenridge, S. C., et al. (2021) · Critical Care Explorations · doi:10.1097/cce.0000000000000374 · Cited by 25

Major determinants of death in patients hospitalized with COVID-19 during the first epidemic wave in Madrid, Spain

Moreno‐Torres, V., de la Fuente, S., Mills, P., Muñoz, A., Múñez, E., Ramos, A., Fernández‐Cruz, A., Arias, A., Pintos-Pascual, I., Vargas, J. A., et al. (2021) · Medicine · doi:10.1097/md.0000000000025634 · Cited by 25

Settling down without settling: Perceived changes in partner preferences in response to COVID-19

Alexopoulos, C., Timmermans, E., Sharabi, L. L., Roaché, D. J., Croft, A., Hall, E. D., James‐Hawkins, L., Lamarche, V. M., & Uhlich, M. (2021) · Journal of Social and Personal Relationships · doi:10.1177/02654075211011527 · Cited by 25

Association of Kidney Disease With Outcomes in COVID‐19: Results From the American Heart Association COVID‐19 Cardiovascular Disease Registry

Rao, A., Ranka, S., Ayers, C. R., HENDREN, N. S., Rosenblatt, A., Alger, H. M., Rutan, C. M., Omar, W. A., Khera, R., Gupta, K., et al. (2021) · Journal of the American Heart Association · doi:10.1161/jaha.121.020910 · Cited by 25

Cardiac biomarkers and COVID-19: A systematic review and meta-analysis

An, W., Kang, J., Wang, Q., & Kim, T. (2021) · Journal of Infection and Public Health · doi:10.1016/j.jiph.2021.07.016 · Cited by 25

Acute myocardial injury in patients with COVID-19: Possible mechanisms and clinical implications

Rusu, I., Turlacu, M., & Micheu, M. M. (2022) · World Journal of Clinical Cases · doi:10.12998/wjcc.v10.i3.762 · Cited by 25

Electrocardiographic Changes in COVID-19 Patients: A Hospital-based Descriptive Study

Kaliyaperumal, D., Kumar, B., Ramaraju, K., Nair, K. S., Ramalingam, S., & Alagesan, M. (2022) · Indian Journal of Critical Care Medicine · doi:10.5005/jp-journals-10071-24045 · Cited by 25

Atherosclerosis, Cardiovascular Disorders and COVID-19: Comorbid Pathogenesis

Makarova, Y. A., Ryabkova, V. A., Салухов, В. В., Sagun, B. V. S., Евгеньевич, К. А., & Churilov, L. P. (2023) · Diagnostics · doi:10.3390/diagnostics13030478 · Cited by 25

Management of patients with digestive diseases during the COVID-19 pandemic: Clinical Practice Guidelines by the Gastroenterological Scientific Society of Russia

Grinevich, V. B., Kravchuk, Y. A., Ped, V. I., Sas, E. I., Salikova, S. P., Владимировна, Г. И., Ei, T., Sitkin, S. I., Лазебник, Л. Б., & Голованова, Е. В. (2020) · Экспериментальная и клиническая гастроэнтерология · doi:10.31146/1682-8658-ecg-179-7-4-51 · Cited by 26

Should Patients Receiving ACE Inhibitors or Angiotensin Receptor Blockers be Switched to Other Antihypertensive Drugs to Prevent or Improve Prognosis of Novel Coronavirus Disease 2019 (COVID-19)?

the Italian Society of Pharmacology, Trifirò, G., Crisafulli, S., Andò, G., Racagni, G., & Drago, F. (2020) · Drug Safety · doi:10.1007/s40264-020-00935-2 · Cited by 26

Engineered nanomaterials as fighters against SARS-CoV-2: The way to control and treat pandemics

Elkodous, M. A., El-Sayyad, G. S., & Abdel‐Daim, M. M. (2020) · Environmental Science and Pollution Research · doi:10.1007/s11356-020-11032-3 · Cited by 25

Inpatient Care of Patients with COVID-19: A Guide for Hospitalists

Yetmar, Z. A., Issa, M., Munawar, S., Burton, M. C., Pureza, V. S., Sohail, M. R., & Mehmood, T. (2020) · The American Journal of Medicine · doi:10.1016/j.amjmed.2020.03.041 · Cited by 25

Involvement of Spike Protein, Furin, and ACE2 in SARS-CoV-2-Related Cardiovascular Complications

Ming, Y., & Qiang, L. (2020) · SN Comprehensive Clinical Medicine · doi:10.1007/s42399-020-00400-2 · Cited by 24

Coronavirus disease 2019 and cardiovascular implications

Frattini, S., Maccagni, G., Italia, L., Metra, M., & Danzi, G. B. (2020) · Journal of Cardiovascular Medicine · doi:10.2459/jcm.0000000000001068 · Cited by 24

Association between renin–angiotensin–aldosterone system inhibitor treatment, neutrophil–lymphocyte ratio, D-Dimer and clinical severity of COVID-19 in hospitalized patients: a multicenter, observational study

Görmez, S., Ekicibaşi, E., Değirmencioğlu, A., Paudel, A., Erdim, R., Kurtoğlu, H., EROĞLU, E., Tanboğa, İ. H., Dağdelen, S., Sarıgüzel, N., et al. (2020) · Journal of Human Hypertension · doi:10.1038/s41371-020-00405-3 · Cited by 24

Cardiac injury prediction and lymphocyte immunity and inflammation analysis in hospitalized patients with coronavirus disease 2019 (COVID-19)

Zhou, W., Song, L., Wang, X., Xu, Z., Wang, S., Wang, J., Xu, H., Yang, Z., & Wang, Y. (2020) · International Journal of Cardiology · doi:10.1016/j.ijcard.2020.10.049 · Cited by 24

Comparison of clinical characteristics among younger and elderly deceased patients with COVID-19: a retrospective study

Tan, X., Zhang, S., Xu, J., Zhou, M. L., Huang, Q., Duan, L., Lv, Z., Xia, H., Xiao, W., Yin, Z., et al. (2020) · Aging · doi:10.18632/aging.202139 · Cited by 24

Renin-angiotensin system blocker and outcomes of COVID-19: a systematic review and meta-analysis

Lee, H. W., Yoon, C., Jang, E. J., & Lee, C. (2021) · Thorax · doi:10.1136/thoraxjnl-2020-215322 · Cited by 24

The peak levels of highly sensitive troponin I predicts in-hospital mortality in COVID-19 patients with cardiac injury: a retrospective study

Wang, Y., Shu, H., Liu, H. S., Li, X., Zhou, X., Zou, X., Pan, S., Xu, J., Xu, D., Zhao, X., et al. (2020) · European Heart Journal Acute Cardiovascular Care · doi:10.1093/ehjacc/zuaa019 · Cited by 24

Potential Role of Gut Microbiota in Traditional Chinese Medicine against COVID-19

Zhang, Q., Yue, S., Wang, W., Chen, Y., Zhao, C., Song, Y., Yan, D., Zhang, L., & Tang, Y. (2021) · The American Journal of Chinese Medicine · doi:10.1142/s0192415x21500373 · Cited by 24

COVID-19 and Acute Myocardial Injury and Infarction: Related Mechanisms and Emerging Challenges

Manolis, A. S., Manolis, T. A., Manolis, T. A., & Melita, H. (2021) · Journal of Cardiovascular Pharmacology and Therapeutics · doi:10.1177/10742484211011026 · Cited by 24

Using Slow-Paced Breathing to Foster Endurance, Well-Being, and Sleep Quality in Athletes During the COVID-19 Pandemic

Borges, U., Lobinger, B., Javelle, F., Watson, M., Mosley, E., & Laborde, S. (2021) · Frontiers in Psychology · doi:10.3389/fpsyg.2021.624655 · Cited by 26

Dapsone, More than an Effective Neuro and Cytoprotective Drug

Díaz-Ruiz, A., Nader, J. A., Calderón‐Estrella, F., Mata-Bermúdez, A., Álvarez-Mejía, L., & Ríos, C. (2021) · Current Neuropharmacology · doi:10.2174/1570159x19666210617143108 · Cited by 24

Chagas disease and SARS-CoV-2 coinfection does not lead to worse in-hospital outcomes

Molina, I., Marcolino, M. S., Pires, M. C., Ramos, L. E. F., Silva, R. T., Júnior, M. H. G., de Oliveira, I. J. R., de Carvalho, R. L. R., Nunes, A. G. S., de Barros, A. L. R. M., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-96825-3 · Cited by 24

Sex-tailored pharmacology and COVID-19: Next steps towards appropriateness and health equity

Spini, A., Giudice, V., Brancaleone, V., Morgese, M. G., Francia, S. D., Filippelli, A., Ruggieri, A., Ziche, M., Ortona, E., Cignarella, A., et al. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.105848 · Cited by 26

Changes in the SARS-CoV-2 cellular receptor ACE2 levels in cardiovascular patients: a potential biomarker for the stratification of COVID-19 patients

Fagyas, M., Bánhegyi, V., Katalin, Ú., Enyedi, A., Lizanecz, E., Mányiné, I. S., Mártha, L., Fülöp, G. Á., Radovits, T., Pólos, M., et al. (2021) · GeroScience · doi:10.1007/s11357-021-00467-2 · Cited by 27

Angiotensin II Promotes SARS-CoV-2 Infection via Upregulation of ACE2 in Human Bronchial Cells

Caputo, I., Caroccia, B., Frasson, I., Poggio, E., Zamberlan, S., Morpurgo, M., Seccia, T. M., Calí, T., Brini, M., Richter, S. N., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23095125 · Cited by 24

COVID-19 Myocarditis: An Emerging Clinical Conundrum

Okor, I., Bob‐Manuel, T., Price, J. H., Sleem, A., Amoran, O., Kelly, J. M., Ekerete, M. F., Bamgbose, M. O., Bolaji, O. A., & Krim, S. R. (2022) · Current Problems in Cardiology · doi:10.1016/j.cpcardiol.2022.101268 · Cited by 25

Nutrition as Personalized Medicine against SARS-CoV-2 Infections: Clinical and Oncological Options with a Specific Female Groups Overview

Dellino, M., Cascardi, E., Vinciguerra, M., Lamanna, B., Malvası, A., Scacco, S., Acquaviva, S., Pinto, V., Vagno, G. D., Cormio, G., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23169136 · Cited by 25

Mucociliary transport deficiency and disease progression in Syrian hamsters with SARS-CoV-2 infection

Li, Q., Vijaykumar, K., Phillips, S. E., Hussain, S. S., Huynh, N. V., Petty, C. F., Lever, J. E. P., Foote, J. B., Ren, J., Campos, J., et al. (2023) · JCI Insight · doi:10.1172/jci.insight.163962 · Cited by 23

COVID-19 cardiac arrest management: A review for emergency clinicians

Ramzy, M. M., Montrief, T., Gottlieb, M. A., Brady, W. J., Singh, M., & Long, B. (2020) · The American Journal of Emergency Medicine · doi:10.1016/j.ajem.2020.08.011 · Cited by 24

Cardiac adverse events associated with chloroquine and hydroxychloroquine exposure in 20 years of drug safety surveillance reports

Cohen, I. V., Makunts, T., Moumedjian, T., Issa, M. A., & Abagyan, R. A. (2020) · Scientific Reports · doi:10.1038/s41598-020-76258-0 · Cited by 24

Kinocardiography Derived from Ballistocardiography and Seismocardiography Shows High Repeatability in Healthy Subjects

Hossein, A., Rabineau, J., Gorlier, D., Rio, J. I. J. D., van de Borne, P., Migeotte, P., & Nonclercq, A. (2021) · Sensors · doi:10.3390/s21030815 · Cited by 24

Predicting critical state after COVID-19 diagnosis: Model development using a large US electronic health record dataset

Rinderknecht, M. D., & Klopfenstein, Y. (2021) · npj Digital Medicine · doi:10.1038/s41746-021-00482-9 · Cited by 23

Epidemiological and clinical characteristics of discharged patients infected with SARS‐CoV‐2 on the Qinghai Plateau

Xi, A., Ma, Z., Dai, J., Ding, Y., Ma, X., Ma, X., Wang, X., Shi, L., Bai, H., Zheng, H., et al. (2020) · Journal of Medical Virology · doi:10.1002/jmv.26032 · Cited by 23

Massive coronary thrombosis caused primary percutaneous coronary intervention to fail in a COVID‐19 patient with ST‐elevation myocardial infarction

Seif, S., Ayuna, A., Kumar, A., & Macdonald, J. (2020) · Catheterization and Cardiovascular Interventions · doi:10.1002/ccd.29050 · Cited by 23

Ecografía en el manejo del paciente crítico con infección por SARS-CoV-2 (COVID-19): una revisión narrativa

Gutiérrez, V. F., Azcárate, J. M. A., Pérez-Torres, D., Zapata, L., Yakushev, A. R., & Ochagavía, A. (2020) · Medicina Intensiva · doi:10.1016/j.medin.2020.04.016 · Cited by 23

Analysis of clinical features and early warning signs in patients with severe COVID-19: A retrospective cohort study

Liu, X., Yue, X., Liu, F., Wei, L., Chu, Y., Bao, H., Dong, Y., Cheng, W., & Yang, L. (2020) · PLoS ONE · doi:10.1371/journal.pone.0235459 · Cited by 23

The Association of Cardiovascular Diseases and Diabetes Mellitus with COVID-19 (SARS-CoV-2) and Their Possible Mechanisms

Roy, S., Mazumder, T., & Banik, S. (2020) · SN Comprehensive Clinical Medicine · doi:10.1007/s42399-020-00376-z · Cited by 23

The Chronicle of COVID-19 and Possible Strategies to Curb the Pandemic

Kumar, R., Harilal, S., Al-Sehemi, A. G., Mathew, G. E., Carradori, S., & Mathew, B. (2020) · Current Medicinal Chemistry · doi:10.2174/0929867327666200702151018 · Cited by 25

A Retrospective Study from 2 Centers in China on the Effects of Continued Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers in Patients with Hypertension and COVID-19

Wang, Z., Zhang, D., Wang, S., Jin, Y., Huan, J., Wu, Y., Xia, C., Li, Z., Qi, X., Duanzhen, Z., et al. (2020) · Medical Science Monitor · doi:10.12659/msm.926651 · Cited by 23

Antibodies at work in the time of severe acute respiratory syndrome coronavirus 2

Sajna, K. V., & Kamat, S. (2020) · Cytotherapy · doi:10.1016/j.jcyt.2020.08.009 · Cited by 22

Cardiac imaging phenotype in patients with coronavirus disease 2019 (COVID-19): results of the cocarde study

Lairez, O., Blanchard, V., Houard, V., Bounes, F. V., Lemasle, M., Cariou, E., Badie, Y. L., Ruiz, S., Cazalbou, S., Delmas, C., et al. (2020) · International journal of cardiac imaging · doi:10.1007/s10554-020-02010-4 · Cited by 23

Crosstalk Between Coronavirus Disease 2019 and Cardiovascular Disease and Its Treatment

Ye, Q., Lu, D., Shang, S., Fu, J., Gong, F., Shu, Q., & Mao, J. (2020) · ESC Heart Failure · doi:10.1002/ehf2.12960 · Cited by 24

A systematic review and meta‐analysis of the use of renin‐angiotensin system drugs and COVID‐19 clinical outcomes: What is the evidence so far?

Kurdi, A. B., Abutheraa, N., Akil, L., & Godman, B. (2020) · Pharmacology Research & Perspectives · doi:10.1002/prp2.666 · Cited by 24

Assessment of Cardiac Arrhythmic Risk in Children With Covid-19 Infection

Ece, İ., Koçoğlu, M., Kavurt, A. V., Bağrul, D., Gül, A. E. K., Koca, S., Çetin, İ. İ., Parlakay, A. N. Ö., & Aksoy, S. (2020) · Pediatric Cardiology · doi:10.1007/s00246-020-02474-0 · Cited by 23

Gamut of Cardiac Manifestations and Complications of COVID-19: A Contemporary Review

Rodriguez, J. B. C., Lange, R. A., & Mukherjee, D. (2020) · Journal of Investigative Medicine · doi:10.1136/jim-2020-001592 · Cited by 25

Type 2 diabetes mellitus impaired nasal immunity and increased the risk of hyposmia in COVID-19 mild pneumonia patients

Zhao, Y., Liu, Y., Yi, F., Zhang, J., Xu, Z., Liu, Y., & Tao, Y. (2021) · International Immunopharmacology · doi:10.1016/j.intimp.2021.107406 · Cited by 26

A super learner ensemble of 14 statistical learning models for predicting COVID-19 severity among patients with cardiovascular conditions

Ehwerhemuepha, L., Danioko, S., Verma, S., Marano, R., Feaster, W. W., Taraman, S., Moreno, T., Zheng, J., Yaghmaei, E., & Chang, A. C. (2021) · Intelligence-Based Medicine · doi:10.1016/j.ibmed.2021.100030 · Cited by 23

Cancer vs. SARS-CoV-2 induced inflammation, overlapping functions, and pharmacological targeting

Subbarao, S. A. (2021) · Inflammopharmacology · doi:10.1007/s10787-021-00796-w · Cited by 24

Is there any role of intermittent fasting in the prevention and improving clinical outcomes of COVID-19?: intersection between inflammation, mTOR pathway, autophagy and calorie restriction

Gnoni, M. L., Beas, R., & Vásquez-Garagatti, R. (2021) · VirusDisease · doi:10.1007/s13337-021-00703-5 · Cited by 23

Predictive Value of Neutrophil/Lymphocyte Ratio (NLR) on Cardiovascular Events in Patients with COVID-19

Zhan, L., Liu, Y., Cheng, Y., Guo, W., & Yang, J. (2021) · International Journal of General Medicine · doi:10.2147/ijgm.s317380 · Cited by 23

Ivermectin Prophylaxis Used for COVID-19: A Citywide, Prospective, Observational Study of 223,128 Subjects Using Propensity Score Matching

Kerr, L., Cadegiani, F., Baldi, F. S., Lôbo, R. B., Assagra, W. L. O., Proença, F. C., Kory, P. D., Hibberd, J. A., & Chamie-Quintero, J. J. (2022) · Cureus · doi:10.7759/cureus.21272 · Cited by 25

Uncovering the Genetic Links of SARS-CoV-2 Infections on Heart Failure Co-Morbidity by a Systems Biology Approach

Zhang, G., Cui, X., Zhang, L., Liu, G., Zhu, X., Shangguan, J., Zhang, W., Zheng, Y., Zhang, H., Tang, J., et al. (2022) · ESC Heart Failure · doi:10.1002/ehf2.14003 · Cited by 24

Cell and Animal Models for SARS-CoV-2 Research

Bestion, E., Halfon, P., Mezouar, S., & Mège, J. (2022) · Viruses · doi:10.3390/v14071507 · Cited by 24

Colorimetric Detection of the SARS-CoV-2 Virus (COVID-19) in Artificial Saliva Using Polydiacetylene Paper Strips

Prainito, C. D., Eshun, G. B., Osonga, F. J., Isika, D., Centeno, C., & Sadik, O. A. (2022) · Biosensors · doi:10.3390/bios12100804 · Cited by 23

The community proactive health management model based on the grounded theory: The case of Beijing, China

He, J., & Wang, T. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e14992 · Cited by 23

Challenges in the management of older patients with acute coronary syndromes in the COVID-19 pandemic

Rowland, B. W., & Kunadian, V. (2020) · Heart · doi:10.1136/heartjnl-2020-317011 · Cited by 23

Computational Model on COVID-19 Pandemic Using Probabilistic Cellular Automata

Ghosh, S., & Bhattacharya, S. (2021) · SN Computer Science · doi:10.1007/s42979-021-00619-3 · Cited by 23

Role of advanced imaging in COVID-19 cardiovascular complications

Catapano, F., Marchitelli, L., Cundari, G., Cilia, F., Mancuso, G., Pambianchi, G., Galea, N., Ricci, P., Catalano, C., & Francone, M. (2021) · Insights into Imaging · doi:10.1186/s13244-021-00973-z · Cited by 23

Advocacy of targeting protease‐activated receptors in severe coronavirus disease 2019

Subramaniam, S., Ruf, W., & Bosmann, M. (2021) · British Journal of Pharmacology · doi:10.1111/bph.15587 · Cited by 23

Sustained Impairment in Cardiopulmonary Exercise Capacity Testing in Patients after COVID-19: A Single Center Experience

Evers, G., Schulze, A. B., Osiaevi, I., Harmening, K., Vollenberg, R., Wiewrodt, R. G., Pistulli, R., Boentert, M., Tepasse, P., Sindermann, J. R., et al. (2022) · Canadian Respiratory Journal · doi:10.1155/2022/2466789 · Cited by 25

Coronavirus disease 2019 and the cardiovascular system: Impacts and implications

Gupta, M. D., Girish, M. P., Yadav, G., Shankar, A., & Yadav, R. K. (2020) · Indian Heart Journal · doi:10.1016/j.ihj.2020.03.006 · Cited by 23

COVID-19: A Matter Close to the Heart

de Oliveira, G. M. M., & Pinto, F. J. (2020) · International Journal of Cardiovascular Sciences · doi:10.36660/ijcs.20200057 · Cited by 23

N-Acetylcysteine in the Treatment of Acute Lung Injury: Perspectives and Limitations

Mokrá, D., Porvazník, I., & Mokrý, J. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26062657 · Cited by 22

Cardiac surgery in the time of the coronavirus

Fudulu, D. P., & Angelini, G. D. (2020) · Journal of Cardiac Surgery · doi:10.1111/jocs.14580 · Cited by 22

Emerging Biomolecular Testing to Assess the Risk of Mortality from COVID-19 Infection

Mahmoudi, M. (2020) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.0c00371 · Cited by 22

Compliance of Antihypertensive Medication and Risk of Coronavirus Disease 2019: a Cohort Study Using Big Data from the Korean National Health Insurance Service

Kim, J., Kim, K., Kim, H. B., Kim, J., Kim, J.-H., Lee, Y.-G., Byeon, K. H., Cheong, H., & the Korean Society of Hypertension (2020) · Journal of Korean Medical Science · doi:10.3346/jkms.2020.35.e232 · Cited by 21

Statistical interpretation of environmental influencing parameters on COVID-19 during the lockdown in Delhi, India

Awasthi, A., Sharma, A., Kaur, P., Gugamsetty, B., & Kumar, A. (2020) · Environment Development and Sustainability · doi:10.1007/s10668-020-01000-9 · Cited by 22

Electrocardiographic Findings and Clinical Outcome in Patients with COVID-19 or Other Acute Infectious Respiratory Diseases

Vita, A. D., Ravenna, S. E., Covino, M., Lanza, O., Franceschi, F., Crea, F., & Lanza, G. A. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9113647 · Cited by 22

The coronavirus disease 2019 and effect on liver function: a hidden and vital interaction beyond the respiratory system

Hosseini, P., Afzali, S., Karimi, M., Zandi, M., Zebardast, A., Latifi, T., Tabibzadeh, A., Ramezani, A., Zakeri, A., Zakeri, A., et al. (2021) · Reviews in Medical Microbiology · doi:10.1097/mrm.0000000000000267 · Cited by 22

Investigation of Coagulation Biomarkers to Assess Clinical Deterioration in SARS-CoV-2 Infection

Billoir, P., Alexandre, K., Duflot, T., Roger, M., Miranda, S., Goria, O., Joly, L. M., Demeyere, M., Feugray, G., Brunel, V., et al. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.670694 · Cited by 22

Nutrition, atherosclerosis, arterial imaging, cardiovascular risk stratification, and manifestations in COVID-19 framework: a narrative review

Munjral, S., Ahluwalia, P., Jamthikar, A. D., Puvvula, A., Saba, L., Faa, G., Singh, I. M., Chadha, P. S., Turk, M., Johri, A. M., et al. (2021) · Frontiers in Bioscience-Landmark · doi:10.52586/5026 · Cited by 22

Sex-Related Factors in Cardiovascular Complications Associated to COVID-19

Megiorni, F., Pontecorvi, P., Gerini, G., Anastasiadou, E., Marchese, C., & Ceccarelli, S. (2021) · Biomolecules · doi:10.3390/biom12010021 · Cited by 22

Malnutrition Contributes to Low Lymphocyte Count in Early-Stage Coronavirus Disease-2019

Zhang, K., Qin, W., Zheng, Y., Pang, J., Zhong, N., Fei, J., Li, Y., Jian, X., Hou, X., Hu, Z., et al. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2021.739216 · Cited by 22

Morphologically, immunohistochemically and PCR proven lymphocytic viral peri-, endo-, myocarditis in patients with fatal COVID-19

Коган, Е. А., Berezovskiy, Y. S., Blagova, O. V., Kukleva, A., Semyonova, L., Gretsov, E., & Эргешов, А. Э. (2022) · Diagnostic Pathology · doi:10.1186/s13000-022-01207-6 · Cited by 22

Clinical Characterization and Possible Pathological Mechanism of Acute Myocardial Injury in COVID-19

Li, S., Wang, J., Yan, Y., Zhang, Z., Gong, W., & Nie, S. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.862571 · Cited by 22

Association of Congenital and Acquired Cardiovascular Conditions With COVID-19 Severity Among Pediatric Patients in the US

Ehwerhemuepha, L., Roth, B. J., Patel, A. K., Heutlinger, O., Heffernan, C., Arrieta, A. C., Sanger, T. D., Cooper, D. M., Shahbaba, B., Chang, A. C., et al. (2022) · JAMA Network Open · doi:10.1001/jamanetworkopen.2022.11967 · Cited by 22

Clinical Features and Outcomes of COVID-19 Patients with Acute Kidney Injury and Acute Kidney Injury on Chronic Kidney Disease

Xu, Z., Zhang, Y., Zhang, C., Xiong, F., Zhang, J., & Xiong, J. (2022) · Aging and Disease · doi:10.14336/ad.2021.1125 · Cited by 22

ENDOTHELIAL BIOMARKERS IN PATIENTS RECOVERED FROM COVID-19 ONE YEAR AFTER HOSPITAL DISCHARGE: A CROSS-SECTIONAL STUDY

Tong, M., Yan, X., Jiang, Y., Jin, Z., Zhu, S., Zou, L., Liu, Y., Zheng, Q., Chen, G., Gui, R. G., et al. (2022) · Mediterranean Journal of Hematology and Infectious Diseases · doi:10.4084/mjhid.2022.033 · Cited by 23

Efficacy and Safety of Shenfu Injection for Severe Pneumonia in the Elderly: A Systematic Review and Meta-Analysis Based on Western and Eastern Medicine

Shi, S., Wang, F., Chen, B., Pan, J., Luo, D., Pei, C., Huang, D., Wang, X., Wang, Y., Shen, Z., et al. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.779942 · Cited by 22

Decades-old renin inhibitors are still struggling to find a niche in antihypertensive therapy. A fleeting look at the old and the promising new molecules

Ramya, K., Suresh, R., Kumar, H. Y., Kumar, B. R. P., & Murthy, N. B. S. (2020) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2020.115466 · Cited by 22

Dilated Cardiomyopathy Risk in Patients with Coronavirus Disease 2019: How to Identify and Characterise it Early?

Komiyama, M., Hasegawa, K., & Matsumori, A. (2020) · European Cardiology Review · doi:10.15420/ecr.2020.17 · Cited by 22

The rapid transformation of cardiac surgery practice in the coronavirus disease 2019 (COVID-19) pandemic: insights and clinical strategies from a centre at the epicentre

George, I., Salna, M. P., Kobsa, S., DeRoo, S. C., Kriegel, J. M., Blitzer, D., Shea, N. J., Shea, D’Angelo, A., Raza, S. T., et al. (2020) · European Journal of Cardio-Thoracic Surgery · doi:10.1093/ejcts/ezaa228 · Cited by 22

Safety perspectives on presently considered drugs for the treatment of COVID‐19

Penman, S. L., Kiy, R. T., Jensen, R. L., Betts, C. B., Alfirevic, A., Back, D. J., Khoo, S., Owen, A., Pirmohamed, M., Park, B. K., et al. (2020) · British Journal of Pharmacology · doi:10.1111/bph.15204 · Cited by 24

Echocardiographic findings in critical patients with COVID-19

Rodríguez-Santamarta, M., Minguito‐Carazo, C., Echarte‐Morales, J., Castillo-García, S. D., Valdivia-Ruiz, J., & Fernández‐Vázquez, F. (2020) · Revista Española de Cardiología (English Edition) · doi:10.1016/j.rec.2020.06.030 · Cited by 22

COVID-19: an update and cardiac involvement

Alwaqfi, N. R., & Ibrahim, K. S. (2020) · Journal of Cardiothoracic Surgery · doi:10.1186/s13019-020-01299-5 · Cited by 19

COVID-19 and Cardiovascular Disease

Chung, M. K., Zidar, D. A., Bristow, M. R., Cameron, S. J., Chan, T. A.-T., Harding, C. V., Kwon, D. H., Singh, T. K., Tilton, J. C., Tsai, E. J., et al. (2021) · Circulation Research · doi:10.1161/circresaha.121.317997 · Cited by 377

Association between COVID-19 and cardiovascular disease

Srivastava, K. (2020) · IJC Heart & Vasculature · doi:10.1016/j.ijcha.2020.100583 · Cited by 33

ACE2 as a Key Target for Treatment of COVID-19 Related Cardiovascular Diseases: Current Progress and Prospect

Li, S., Ma, W., Yang, F., Xu, Y., Xu, B., & Cai, B. (2021) · Current Drug Targets · doi:10.2174/1389450122666210319110320 · Cited by 1

Mechanisms and treatments of myocardial injury in patients with corona virus disease 2019

Peng, W., Wu, H., Tan, Y. L., Li, M., Yang, D., & Li, S. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118496 · Cited by 12